Publications

U-M MEND Division, Dr. Elif Oral Publications

 
 
 
 
 

Selected Publications:

  1. Ajluni NN, Meral R, Neidert AH, Brady GF, Buras E, McKenna B, DiPaola F, Chenevert TL, BuggsSaxton C, Rupani AR, Thomas PE, Tayeh MK, Innis JW, Bishr Omary M, Conjeevaram H, Oral EA. Spectrum of Disease in Partial Lipodystrophy (PL): Lessons from a Trial Cohort. The Journal of Clinical Endocrinology & Metabolism. February 15, 2017. doi: 10.1111/cen.13311. PMID: 28199729
  2. Lager CJ, Esfandiadari NH, Sabauste AR, Kraftson AT, Brown MB, Cassidy RB, Bellers D, Lockwood AL, Varban OA, Oral EA. Milestone Weight Loss Goals (Weight Normalization and Remission of Obesity) after Gastric Bypass Surgery: Long-Term Results from the University of Michigan Obesity Surgery, January 13, 2017. doi: 10.1007/s11695-016-2533-1. PMID: 28084587
  3. Lager CJ, Esfandiari NH, Subauste AR, Kraftson AT, Brown MB, Cassidy RB, Nay CK, Lockwood AL, Varban OA, Oral EA. Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: Balancing the Risks of Surgery with the Benefits of Weight Loss. Obesity Surgery, 27(1):154-161, January 2017. doi: 10.1007/s11695- 016-2265-2. PMID: 27342739
  4. Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother KI, von Schnurbein J, Sorkina E, Stanley T, Vigouroux C, Wabitsch M, Williams R, Yorifuji T. The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 101(12):4500–4511, December 2016. PMID: 27710244
  5. Walden PS, Jiang Q, Jackson E, Oral EA, Rubenfire M. Assessing the Incremental Benefit of an Extended Duration Lifestyle Intervention for the Components of the Metabolic Syndrome. Journal of Diabetes, Metabolic Syndrome and Obesity, 9: 177-84, June 1, 2016. doi: 10.2147/DMSO.S94772. eCollection 2016. PMID: 27330320
  6. Ajluni N, Dar M, Xu J, Neidert AH, Oral EA. Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program. Journal of Diabetes and Metabolism, 7(3). pii: 659, March 2016. PMID: 27642538
  7. Chan JL, Koda J, Helig JS, Cochran EK, Gorden P, Oral EA, Brown RJ. Immunogenicity Associated with Metreleptin in Patients with Obesity or Lipodystrophy. Clinical Endocrinology (Oxford), 85(1):137-49, July 2016. doi: 10.1111/cen.12980. Epub February 2, 2016, PMID: 26589105
  8. Oral EA. Closing the Knowledge Gap on Cardiovascular Disease in Type 2 Diabetes: The EMPA-REG OUTCOME Trial and Beyond. Drugs in Context, 5:212299, 2016. doi: 10.7573/dic.212299. PMID: 27648101